期刊文献+

1786例血小板输注的疗效分析 被引量:21

Analysis on Effectiveness of Platelet Transfusion in 1786 Patients
下载PDF
导出
摘要 本研究旨在观察及分析临床血小板输注的疗效。用全自动血细胞分析仪检测1786例患者血小板输注前及输注后20-24 h静脉血中血小板数,计算血小板回收率(PPR),结合输注血小板后出血表现判断输注疗效,并根据病因、输注次数、输注的血小板种类及是否一次性足量输注对血小板输注有效率进行统计学分析。结果表明:1786例患者总血小板输注有效率为52.5%。按不同病因分组的组间血小板输注有效率有统计学差异(P<0.01),其中白血病组和再生障碍性贫血(AA)组血小板输注有效率最低,与其余组比较均有统计学差异(P<0.05),手术组的血小板输注有效率最高。按血小板输注次数分组的组间血小板输注有效率有统计学差异(P<0.01),且随着输注次数的增加,血小板输注有效率逐步降低。按输注的血小板种类分组,浓缩血小板组(一次足量输注)和单采血小板组血小板输注有效率有统计学差异(P<0.01)。浓缩血小板输注按是否一次性足量输注分组:血小板输注有效率组间无统计学差异(P>0.05)。结论:患者病因和输注次数与血小板输注有效率密切相关;血小板输注次数越多,血小板输注无效的可能性越高;单采血小板疗效明显优于浓缩血小板;浓缩血小板血小板是否足量输注与输注有效率无显著性相关。 This study was aimed to observe and analyze the effectiveness of platelet transfusion.The platelet count of 1786 patients before transfusion and on 20-24 hours after transfusion was determined by using Auto-Hematology Analyzer,the percent platelet recovery(PPR) was calculated,the platelet transfusion efficiency(PTE) was evaluated by PPR and hemorrhage presentation after platelet transfusion,and the PTE was statistically analyzed according to disease cause,transfusion frequency,platelet type and once transfusion amount.The results showed that the total PTE of 1786 patients was 52.5%.The comparion of PTE among groups of diesease cause showed that PTE in luekemia and aplastic anemia(AA) was lowest,as compared with that of other diseases(P〈0.05),while PTE in operation group was highest.The comparison of PTE among groups of transfusion frequency revealed also statistical difference(P〈0.01),meanwhile PTE decreased with increasing of transfusion frequency.The comparion of PTE among groups of platelet type(platelet phoresis or platelet concentrate) showed statistical difference(P〈0.01).The comparison of PTE among groups of platelet concentrate of once transfusion amount showed no stastistcal difference(P〈0.05).It is concluded that the PTE closely relates with disease cause of patients,moreover transfusion frequency also associates with PTE,the more frequency of transfusion,the higher possibility of transfusion refractoriness.The PTE of platelet pheresis is obviously superior to that of platelet concentrate,while PTE of platelet concentrate not significantly relates with once adeguate or not.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第4期1038-1041,共4页 Journal of Experimental Hematology
基金 贵州省科技计划课题研究项目(黔科合LS字[2011]006号) 贵阳市科技计划项目(筑科合同[2011103]41号)
关键词 血小板输注无效 血小板回收率 再生障碍性贫血 血小板减少性紫癜 platelet transfusion refractoriness percent platelet recovery aplastic anemia idiopathic thrombocytopenic purpum
  • 相关文献

参考文献11

  • 1傅菊芳,王小芳,戴月娥,李蕊,白燕妮,杨宏宇,郑善峦.血液病患者血小板输注效率的分析与护理[J].中华护理杂志,2000,35(10):596-598. 被引量:18
  • 2桂嵘,聂新民,文贤慧,刘竞.临床727例次单采血小板输注效果分析[J].中国实验血液学杂志,2012,20(2):381-385. 被引量:24
  • 3Novotny VM. Prevention and management of platelet transfusion re- fractoriness. Vox Sang, 1999 ;76 ( 1 ) : 1 - 13.
  • 4胡丽华.检验与临床诊断分析.北京:人民军医出版社,2009:60-62.
  • 5王一,王存彪,钱林生.血小板无效输注及治疗策略[J].国外医学(输血及血液学分册),2001,24(4):339-342. 被引量:31
  • 6张海燕,侯明,张小红,关向宏,孙桂珍.血小板特异性抗体对特发性血小板减少性紫癜诊断价值的研究[J].中国实验血液学杂志,2004,12(2):204-206. 被引量:11
  • 7Heuer L, Blumenberg D. Management of bleeding in a multi-trans- fused patient with positive HLA class I alloantibodies and thrombocy- topenia associated with platelet dysfunction refractory to transfusion of cmssmatched platelets. Blood Coagul Fibrinolysis, 2005 ; 16 (4) : 287 - 290.
  • 8Rebulla P. Refractoriness to platelet transfusion. Curr Opin Hematol, 2002;9(6) :516-520.
  • 9兰炯采.血小板抗体检测的若干问题[J].中国输血杂志,1997,10(4):216-217.
  • 10Murphy MF, Metcalfe P, Thomas H ,et al. Use of leukocyte poor blood components and HLA match platelet donors to prevent HLA al- loimmunization. Br J Hematol,1986;62(4) :529 -534.

二级参考文献22

  • 1阎石,韩平.血小板输注无效的临床问题[J].中华血液学杂志,1993,14(12):659-660. 被引量:31
  • 2王涓冬,潘祥林,尹哲,孙俊华,孔桂香,陈颖洁,姜翠英,窦爱霞,王志仑.血小板糖蛋白特异性抗体在骨髓增生异常综合征患者中的表达及其意义[J].中国实验血液学杂志,2007,15(1):95-98. 被引量:6
  • 3叶兵.输血后血小板同种免疫:一项117例心脏外科手术病人的前展性研究[J].国外医学:输血及血液学分册,1998,21(3):200-200.
  • 4费世柏.抗生素对输血后血小板增加值的影响[J].国外医学:输血及血液学分册,1997,20(5):318-318.
  • 5Bessos H, Wilson DW, Metcalfe P, et al. Report on the 12th international society of blood transfusion platelet immunology workshop. Vox Sanguinis,2005 ;89(2) :105 - 113.
  • 6Tasaki T, Fujii K, CJotoh K, et al. Pre-transfusion screening for platelet-reactive antibodies. Transfus Apher Sci ,2005 ;33 (2) :157 - 164.
  • 7高峰,主编.临床检验血液学.北京:人民卫生出版社.2003:149.
  • 8Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Onco1,2007 ; 19 ( 5 ) : 1519 - 1538.
  • 9Cines DB, Blanchette VS, Chir B. Immune thrombocytopenic purpura. N Engl J Med,2002;346:995-1008
  • 10McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol,2000;37:239-248

共引文献95

同被引文献166

引证文献21

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部